Wellesley Pharmaceuticals utilizes world class consultants and partners as needed to work quickly and efficiently towards our goals.
CEO and President, Wellesley Pharmaceuticals, LLC
Currently serves as Director of Operations and Chief Operating Officer at The Lenfest Institute for Journalism
Dr. Michael Myers is CoFounder, Chief Executive Officer and Director of Quoin Pharmaceuticals
PLEASE NOTE THAT NOCTUROL HAS NOT BEEN APPROVED BY THE FDA OR EMA OR ANY OTHER REGULATORY AUTHORITY. NOCTUROL IS CURRENTLY UNDERGOING A PHASE 2 CLINICAL TRIAL.